These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6189106)

  • 21. High plasma estradiol-17beta levels in dogs with benign prostatic hyperplasia and azoospermia.
    Kawakami E; Amemiya E; Namikawa K; Kashiwagi C; Hori T; Tsutsui T
    J Vet Med Sci; 2001 Apr; 63(4):407-12. PubMed ID: 11346175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.
    Ortega E; Ruiz E; Mendoza MC; Martin-Andres A; Osorio C
    Experientia; 1979 Jun; 35(6):844-5. PubMed ID: 89045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum steroids in relation to benign prostatic hyperplasia.
    Lagiou P; Mantzoros CS; Tzonou A; Signorello LB; Lipworth L; Trichopoulos D
    Oncology; 1997; 54(6):497-501. PubMed ID: 9394847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-hormone-binding globulin in the plasma of normal men and patients with benign prostatic hypertrophy.
    Minguell JJ; Merino J; Valladares LE; Troncoso S
    Arch Androl; 1979; 3(2):167-71. PubMed ID: 92918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
    Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
    Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment plasma levels of testosterone and sex hormone binding globulin binding capacity in relation to clinical staging and survival in prostatic cancer patients.
    Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
    Prostate; 1988; 12(4):325-32. PubMed ID: 3393494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease.
    Grosman H; Fabre B; Lopez M; Scorticati C; Lopez Silva M; Mesch V; Mazza O; Berg G
    Aging Male; 2016; 19(1):40-5. PubMed ID: 26526283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
    Meunier ME; Neuzillet Y; Raynaud JP; Radulescu C; Ghoneim T; Fiet J; Giton F; Rouanne M; Dreyfus JF; Lebret T; Botto H
    Prostate; 2019 Feb; 79(3):272-280. PubMed ID: 30370569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the role of sex-hormone-binding globulin (SHBG) in benign prostatic hypertrophy in men. I. Clinical research.
    Pachman A
    Int Urol Nephrol; 1984; 16(2):141-7. PubMed ID: 6206017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free estradiol, free testosterone, and sex hormone-binding globulin in perimenopausal women.
    Longcope C; Hui SL; Johnston CC
    J Clin Endocrinol Metab; 1987 Mar; 64(3):513-8. PubMed ID: 3102538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low serum testosterone levels are predictive of prostate cancer.
    Mearini L; Zucchi A; Nunzi E; Villirillo T; Bini V; Porena M
    World J Urol; 2013 Apr; 31(2):247-52. PubMed ID: 22068548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.
    Partin AW; Oesterling JE; Epstein JI; Horton R; Walsh PC
    J Urol; 1991 Feb; 145(2):405-9. PubMed ID: 1703242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma sex hormone binding globulin in patients with prostatic carcinoma.
    Grasso M; Buonaguidi A; Mondina R; Borsellino G; Lania C; Banfi G; Rigatti P
    Cancer; 1990 Jul; 66(2):354-7. PubMed ID: 1695120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum prolactin and tumors of the prostate: unchanged basal levels and lack of correlation to serum testosterone.
    Jacobi GH; Rathgen GH; Altwein JE
    J Endocrinol Invest; 1980; 3(1):15-8. PubMed ID: 6154729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
    Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
    Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of serum sex-steroid hormones and prostate volume in African American men.
    Joseph MA; Wei JT; Harlow SD; Cooney KA; Dunn RL; Jaffe CA; Montie JE; Schottenfeld D
    Prostate; 2002 Dec; 53(4):322-9. PubMed ID: 12430143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.